|
ZNF230 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.343110E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93870000053664E-07 |
| Normal-vs-Stage2 |
1.832400E-01 |
| Normal-vs-Stage3 |
9.014000E-01 |
| Normal-vs-Stage4 |
7.851000E-01 |
| Stage1-vs-Stage2 |
7.889800E-02 |
| Stage1-vs-Stage3 |
2.28220000009216E-07 |
| Stage1-vs-Stage4 |
3.59850000020145E-07 |
| Stage2-vs-Stage3 |
2.071800E-01 |
| Stage2-vs-Stage4 |
1.427760E-01 |
| Stage3-vs-Stage4 |
6.959800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.162830E-03 |
| Normal-vs-AfricanAmerican |
2.541800E-01 |
| Normal-vs-Asian |
1.792420E-01 |
| Caucasian-vs-AfricanAmerican |
4.509200E-01 |
| Caucasian-vs-Asian |
9.009200E-01 |
| AfricanAmerican-vs-Asian |
7.016800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.463600E-03 |
| Normal-vs-Female |
7.076200E-03 |
| Male-vs-Female |
9.104000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.686400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.011500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.349690E-02 |
| Normal-vs-Age(81-100Yrs) |
9.810800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.311800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.229800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.931600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.669850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.207380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.311600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.762800E-03 |
| Normal-vs-Grade 2 |
6.46479999533156E-08 |
| Normal-vs-Grade 3 |
1.626840E-01 |
| Normal-vs-Grade 4 |
1.446380E-02 |
| Grade 1-vs-Grade 2 |
9.419800E-02 |
| Grade 1-vs-Grade 3 |
1.648370E-02 |
| Grade 1-vs-Grade 4 |
1.682190E-03 |
| Grade 2-vs-Grade 3 |
1.65620000003308E-06 |
| Grade 2-vs-Grade 4 |
1.93034477291576E-12 |
| Grade 3-vs-Grade 4 |
1.768400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.39220002193241E-09 |
| Normal-vs-ccB subtype |
7.199200E-01 |
| ccA subtype-vs-ccB subtype |
3.68139996265171E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.208450E-02 |
| Normal-vs-N1 |
1.634050E-01 |
| N0-vs-N1 |
5.590300E-02 |
|
|
